Times are a little tough right now for all of us. I know I've had to tighten my financial belt somewhat with higher gas prices, grocery prices, my electric bill and so on. That's why we work hard every day, gathering, preparing and delivering what we hope are stories that help you in your everyday life. If we happen to be missing items that are important to you, please send me an email. Let me know what you think of the Morning Rush. I'd love to hear from you!
New research from Northwestern University Feinberg School of Medicine talks about a promising new Alzheimer's drug that halts memory loss. It's actually a new class of drug-like small molecules and it's showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer's Disease.
It was developed in the laboratory of Doctor Martin Watterson. The molecules halted memory loss and fixed damaged communication among brain cells in a mouse model of Alzheimer's. Watterson is the lead author on the study and he says this is the starting point for the development of a new class of drugs. Can you imagine how popular this drug would be? This might even top Lipitor or Viagra. Researchers say it's possible someday this class of drugs could be given early on people to arrest certain aspects of Alzheimer's.
Changes in the brain actually start to occur 10 to 15 years before serious memory problems become apparent in Alzheimer's. Researchers say this class of drugs could be beneficial when the nerve cells are just beginning to become impaired.
This is perhaps some of the most exciting medical research news I've heard in years. The key to Alzheimer's it seems, is like many other diseases, survival is best when detected and treated early.